Company Filing History:
Years Active: 2002-2015
Title: The Innovative Contributions of Esa T. Jarvi in the Field of Opiate Alkaloids
Introduction
Esa T. Jarvi, an accomplished inventor based in Ballwin, MO, has made significant contributions to the field of chemistry with a focus on opiate alkaloids. With six patents to her name, Jarvi has pioneered processes that enhance the efficiency and purity of drug production, reflecting her expertise and dedication to scientific innovation.
Latest Patents
Among her notable inventions, Esa T. Jarvi has developed a patent titled "Preparation of Normorphinans." This invention outlines processes for synthesizing normorphinans from N-substituted morphinans, detailing methods for the removal of the N-substituent to create normorphinan carbamates, and subsequently removing the carbamate functionality to obtain pure normorphinans. Another significant patent, "Processes for the Alkylation of Norbuprenorphine with Reduced Impurity Formation," provides innovative processes for producing opiate alkaloids, particularly buprenorphine and its derivatives, while minimizing the formation of impurities.
Career Highlights
Esa T. Jarvi is currently employed at Mallinckrodt, Inc., a company known for its deep commitment to developing innovative pharmaceutical products. Her research and inventions contribute to the company's mission of providing effective therapies for patients in need, showcasing her vital role within the organization.
Collaborations
Jarvi frequently collaborates with esteemed colleagues such as James R. Meyer and Robert E. Halvachs, enhancing her research through teamwork and shared expertise. These collaborations enrich the innovation process and lead to the development of groundbreaking solutions in the pharmaceutical sector.
Conclusion
Esa T. Jarvi exemplifies the impact of dedication and creativity in the field of chemistry and pharmaceuticals. Through her inventions, she continues to drive advancements in drug development, resolving challenges associated with impurity formation and the synthesis of complex compounds. Her work not only serves the pharmaceutical industry but also signifies the importance of innovation in improving healthcare outcomes.